Quantcast
Last updated on April 17, 2014 at 9:10 EDT

Latest tumor Stories

2013-06-25 23:01:51

BerriProducts LLC, an Oregon-based supplier of premium quality black raspberry products shares news from the recently-attended Berry Health Benefits Symposium on angiogenesis inhibition with an in vitro test on human carcinoid cancer cells Charlotte, North Carolina (PRWEB) June 25, 2013 Dr. Eugene Woltering, Section Chief of Surgical Endocrinology at the Louisiana State University Health Sciences Center in New Orleans presented some results of his work on neuroendocrine tumors (NETS)....

2013-06-25 13:08:08

Research paper in the Journal of Pathology reveals protein's role in tumor microenvironment Researchers at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute have uncovered for the first time the vital role a popular protein plays in the stroma, the cell-lined area outside of a prostate tumor. Researchers have long understood the function of the protein, Caveolin-1 (Cav-1), in prostate cancer, including its role in treatment resistance and disease aggressiveness. However,...

2013-06-24 23:15:29

Author Kevin Ryan bridges information gap in cancer treatment. FAIRFIELD, Calif. (PRWEB) June 24, 2013 Information is the best weapon in the fight for your life. Author Kevin Ryan, MD, FACP, empowers patients with knowledge in his book, “When Tumor is the Rumor and Cancer is the Answer.” In the book, Ryan uses authoritative and informative language to guide patients from diagnosis through treatment and even death. The goal, he says, is to make patients active participants in their...

2013-06-11 20:57:05

Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, according to a study from the G.O. Discovery Lab team and collaborators at UCLA. Like tumors of the breast and prostate, endometrial cancer is regulated by hormones. Unlike therapies for breast and prostate cancer, where drugs are given to block hormone signaling, in...

2013-06-11 14:47:44

Comprehensive dosimetry based on 3D medical images estimate best possible dose for targeted radioimmunotherapy (RIT) in patients with invasive blood cancer Outcomes can be bleak for non-Hodgkin lymphoma (NHL), a cancer that develops in the white blood cells of the immune system. Accurate estimation of radiation absorbed dose in radioimmunotherapy (RIT) based on state-of-the-art 3D imaging could lead to more personalized and effective treatments to improve patients´ chances of living...

2013-06-07 12:51:56

In our daily lives, clutter is something that gets in our way, something that makes it harder for us to accomplish things. For doctors and scientists trying to parse mountains of raw biological data, clutter is more than a nuisance; it can stand in the way of figuring out how best to treat someone who is very sick. Using increasingly cheap and rapid methods to read the billions of "letters" that comprise human genomes — including the genomes of individual cells sampled from cancerous...

2013-06-06 23:03:05

A novel gene variant found in human and animal tissue may be a promising treatment for cancer, including breast and brain cancer, according to scientists from the Icahn School of Medicine at Mount Sinai. New York, NY (PRWEB) June 06, 2013 A novel gene variant found in human and animal tissue may be a promising treatment for cancer, including breast and brain cancer, according to scientists from the Icahn School of Medicine at Mount Sinai. The variant, called PTEN-long, may contribute to a...

2013-06-06 08:30:05

Fifth Validation Study Demonstrating Ability to Identify Tumor Origin in Patients with Cancer of Unknown or Uncertain Primary Shows 92% Accuracy, Highest Published Level to Date PHILADELPHIA and REHOVOT, Israel, June 6, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that a manuscript reporting data validating the clinical utility of the Rosetta Cancer Origin Test((TM)) (formerly...

2013-06-05 12:30:42

TSX: AMF TORONTO, June 5, 2013 /CNW/ - Amorfix Life Sciences announced today that it has completed a second series of studies in a preclinical ovarian cancer animal model.  The Company recently reported positive results of the first proof of concept study evaluating the ability of their lead ovarian cancer antibody drug conjugate (ADC) to reduce tumor growth in a rapidly growing animal model of ovarian cancer.  These most recent data confirm this activity in a second, more...

Genetic Traits Of Cells Responsible For One Type Of Brain Cancer Discovered
2013-06-04 08:32:15

redOrbit Staff & Wire Reports — Your Universe Online The genetic traits of glial cells -- the cells which give rise to the most common form of malignant brain cancer in humans -- have been identified by a team of researchers led by University of Rochester Medical Center (URMC) neurologist Dr. Steven Goldman. “This study identifies a core set of genes and pathways that are dysregulated during both the early and late stages of tumor progression,” Goldman, senior...